Bryan C. Hanson was appointed President and Chief Executive Officer and a member of the Board of Directors of Zimmer Biomet in December 2017.
Prior to joining Zimmer Biomet, Mr. Hanson served as a member of Medtronic’s Executive Committee and as Executive Vice President and Group President, Minimally Invasive Therapies Group of Medtronic, where he oversaw and provided strategic direction to that approximately $9 billion business. Prior to joining Medtronic, Mr. Hanson served as Group President, Covidien, with global responsibility for all Covidien business segments. Prior to being elevated to that newly created position, Mr. Hanson served as Group President, Medical Devices & U.S. of Covidien and prior to that, he served as Group President, Surgical Solutions and President, Energy-based Devices. Mr. Hanson began his career with Covidien in 1992. He holds a Bachelor of Science degree in Finance from Florida State University. He also completed the Kellogg School of Management Finance for Executives program in 2010 and the Harvard Executive Education in Leadership program in 2013. Mr. Hanson serves on the board of AmeriCares, an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis.
Aure Bruneau was appointed Group President with responsibility for the Company’s, Spine, Craniomaxillofacial, Thoracic and Surgery Assisting Technology businesses in December 2017.
Mr. Bruneau served as Vice President and General Manager with global responsibility for the Company’s Craniomaxillofacial and Thoracic businesses from June 2015. Mr. Bruneau also led the integration of the Robotics business until assuming his current role. Previously, he served in Vice President roles of increasing responsibility in marketing, business development and general management at Biomet from September 2008 until June 2015. Prior to joining Biomet, Mr. Bruneau held numerous positions with Sofamor Danek Group and Medtronic over a 12-year period. He began his career in the medical device industry while pursuing a Bachelor of Arts in International Studies from the University of Memphis. After receiving his degree, Mr. Bruneau served as a distributor sales associate, followed by a role in international marketing with a focus on Asian markets. He then held several global leadership roles within new market development initiatives. Mr. Bruneau is a native of France.
Tony Collins was appointed Chief Financial Officer, Orthopedics Group in January 2019.
Previously, Mr. Collins served as Vice President, Finance for Zimmer’s Global Reconstructive Division and Global Operations organization. He joined Zimmer in 2010 as Vice President, Finance for the Global Reconstructive Division and U.S. Commercial organization. Prior to joining Zimmer, Mr. Collins held the position of Vice President, Finance and served as the CFO of the Commercial segment of Oshkosh Corporation from 2007 to 2010. From 1997 to 2007, he was employed at Guidant Corporation and Boston Scientific, where he held a number of positions of increasing responsibility, including Finance Director and CFO of the Guidant Japan organization, Global Director of Operations Finance and Director of Strategic Planning. Mr. Collins began his career at PricewaterhouseCoopers LLC. He holds a Bachelor of Science in Accounting from Miami University and an MBA from the University of Michigan.
Derek Davis was appointed Vice President, Global Integration effective June 2015. He took on the additional role of Interim Vice President, Investor Relations in November 2017. Mr. Davis has direct responsibility for the oversight and management of integration activities following the merger of Zimmer and Biomet. In his Investor Relations role, he serves with our Chief Financial Officer as the Company’s key point of contact for members of the investment and financial community.
Mr. Davis served as Vice President, Finance and Corporate Controller and Chief Accounting Officer of the Company from May 2007 until June 2015. He joined the Company (then Zimmer) in 2003, and has held positions of increasing responsibility since that time, including Director of Operations Finance and Director of Financial Planning and Analysis and Corporate Accounting. Prior to joining Zimmer, Mr. Davis served as Vice President, Finance and Corporate Controller for International Wire and as Senior Financial Analyst for Phelps Dodge Corporation. He has more than 15 years of experience in corporate finance, accounting, planning and analysis, cost accounting and operations management. Mr. Davis holds a Bachelor of Science in Accounting and an MBA from Indiana University and is a CPA.
Didier Deltort was appointed President, Europe, Middle East and Africa in August 2018. He is responsible for the marketing, sales and distribution of products, services and solutions in the European, Middle Eastern and African (EMEA) regions.
Prior to joining Zimmer Biomet, Mr. Deltort served as Senior Vice President and General Manager, Global Healthcare Solutions and Partnerships at Boston Scientific Corporation, based in France from May 2016 until August 2018. Before joining Boston Scientific Corporation, he spent 14 years with GE Healthcare in positions of increasing responsibility in Germany, Finland, Dubai and the United States, most recently serving as Global Senior Vice President and General Manager of the global Monitoring Solutions business as well as Managing Director of GE Healthcare Finland. Prior to GE, Mr. Deltort served Philips and Hewlett-Packard as well as Marquette Electronics in various international healthcare executive roles. He holds a Master’s degree in Biomedical Engineering from University de Technologie de Compiègne, France.
Rachel Ellingson was appointed Senior Vice President, Strategy in April 2018.
Prior to joining the Company, Ms. Ellingson served as Vice President, Corporate Strategy and as a member of the executive leadership team at St. Jude Medical. Before joining St. Jude Medical, she served as Vice President, Business Development and Investor Relations at AGA Medical Corporation. Previously, she served in a number of leadership roles in investment banking firms, including Bank of America and Cowen & Company. Ms. Ellingson holds a Bachelor of Arts degree from the University of Rhode Island and an MBA in Finance from the University of Connecticut.
Dan Florin was appointed Senior Vice President and Chief Financial Officer effective June 2015.
Mr. Florin served as Senior Vice President and Chief Financial Officer of Biomet from June 2007 to June 2015. Prior to joining Biomet, Mr. Florin served as Vice President and Corporate Controller of Boston Scientific Corporation from 2001 until 2007. Before being appointed Corporate Controller in 2001, Mr. Florin served in financial leadership positions within Boston Scientific Corporation and its various business units. Prior to joining Boston Scientific Corporation, Mr. Florin worked for C.R. Bard from October 1990 through June 1995, and was employed by Deloitte from September 1986 to October 1990. Mr. Florin holds a Bachelor’s degree in Business Administration with a concentration in Accounting from the University of Notre Dame and an Executive MBA from Boston University.
Monica Kendrick was appointed Vice President, Corporate Communications in July 2015. She is responsible for overseeing global public relations, corporate social responsibility and internal and field communications.
Ms. Kendrick joined the Company (then Zimmer) in June 2010 as Director, Corporate Communications. Prior to joining Zimmer, she oversaw healthcare communications at Cummins, Inc. Previously, she spent more than 15 years at Anthem Blue Cross and Blue Shield in a number of communications positions. Ms. Kendrick holds a Bachelor of Science degree in Business from Indiana University Kelley School of Business.
David Kunz was appointed Senior Vice President, Global Quality, Clinical and Regulatory Affairs in April 2016. He is responsible for providing strategic and operational direction to achieve Quality and Regulatory Excellence across the organization and he chairs the Company’s Quality Excellence Steering Committee.
Mr. Kunz joined the Company (then Zimmer) in 2011 as Vice President, Regulatory Affairs and Quality Assurance for the Spine division. Prior to joining Zimmer, he served as Vice President, Quality Assurance of Ecolab, where he led a supply chain network including nine chemical plants and two equipment plants. Previously, he spent 13 years at Guidant/Boston Scientific Corporation in a variety of leadership positions, most recently as the Director of Supplier Quality Assurance for the CRV Division. He began his career at the Naval Nuclear Propulsion Program Headquarters as a mechanical engineer. Mr. Kunz holds a Bachelor of Science and an MBA from the University of Minnesota. He is a certified Nuclear Engineer and previously was a certified Licensed Professional Mechanical Engineer.
Cole Lannum was appointed Senior Vice President, Investor Relations in March 2018. He is responsible for consulting with executive management on shareholder value optimization and strengthening investor communications both internally and throughout the broader investment community.
Prior to joining the Company, Mr. Lannum served as Senior Vice President, Investor Strategy and Investor Relations Officer for Mallinckrodt Pharmaceuticals. Prior to joining Mallinckrodt, he led Investor Relations at Covidien and Tyco Healthcare for nine years as Vice President and Investor Relations Officer. Mr. Lannum holds a Bachelor of Science in Business Administration from Washington University and a Master of Business Administration from Texas A&M University.
Angela Main was appointed Senior Vice President, Global Chief Ethics and Compliance Officer in June 2015. She is responsible for the provision of compliance advice and ethical solutions to the Zimmer Biomet organization, including developing, operating and monitoring the Company’s Compliance Program.
Ms. Main served as Vice President, Legal and Compliance, Asia Pacific for Zimmer Biomet from September 2010 to June 2015. Prior to joining the Company in 2010, she worked for Covidien in Singapore, Lloyds TSB Bank plc in London and Texas Instruments in its European and Asia Pacific regional offices. She has extensive international legal and compliance experience in the healthcare, financial services and technology sectors.
Pedro Malha was appointed President of Zimmer Biomet’s Dental division in December 2018. Mr. Malha served as Vice President of Zimmer Biomet’s Dental division from May 2017 to December 2018.
Prior to joining the Company, Mr. Malha served as Divisional Vice President at Abbott Medical Optics. Prior to that, he served in international senior leadership positions in Abbott Diabetes Care and Abbott Pharmaceuticals. Before joining Abbott, he held several positions of increasing responsibility at Johnson & Johnson. Mr. Malha holds a Bachelor of Science in Business from Bentley University and an MBA from Boston University. He is a native of Portugal.
Chad Phipps was appointed Senior Vice President, General Counsel and Secretary in May 2007. He has global responsibility for the Company’s Legal Affairs and he serves as Secretary to the Board of Directors. Mr. Phipps also oversees the Company’s Government Affairs, Corporate Communication and Public Relations activities.
Mr. Phipps joined the Company (then Zimmer) in September 2003. Prior to joining Zimmer, he served as Vice President and General Counsel of L&N Sales and Marketing, Inc. in Pennsylvania and he practiced law with the firm of Morgan, Lewis & Bockius in Philadelphia, focusing on corporate and securities law, mergers and acquisitions and financial transactions. Mr. Phipps holds a Bachelor of Arts, magna cum laude, from Rollins College and a J.D. from Villanova University School of Law.
Pamela Puryear was appointed Senior Vice President, Chief Human Resources Officer in January 2019.
Dr. Puryear has extensive global leadership experience in human resources, including three years with Pfizer, where she served as Senior Vice President and Chief Talent Officer. While at Pfizer, Dr. Puryear was responsible for leadership development, talent management, learning and development, employee engagement, organizational culture, diversity and inclusion and workforce analytics. She joined Pfizer from Hospira Inc., where she spent six years as Vice President, Organization Development and Chief Talent Officer. Before joining Hospira, Dr. Puryear was an independent external organizational development consultant for 12 years. Dr. Puryear spent the first 10 years of her career in financial services in the real estate investment advisor industry. Dr. Puryear holds a Ph.D. in organizational psychology, an MBA from Harvard Business School, and a bachelor’s degree in psychology with a concentration in organizational behavior from Yale University.
Zeeshan Tariq was appointed Vice President and Chief Information Officer in July 2016.
Prior to joining the Company, Mr. Tariq spent 17 years at Medtronic, where he served in a number of positions of increasing responsibility, most recently as Vice President and Chief Information Officer, Cardiovascular Group. Prior to joining Medtronic, he worked in the Management Consulting, Systems Consulting and Banking industries. Mr. Tariq holds a Bachelor of Business Administration in Finance, Economics and Management Information Systems from the University of Nebraska; a Master of Science in Software Engineering from the University of Minnesota; and an MBA from the Carlson School of Management.
Ivan Tornos was appointed Group President, Orthopedics in November 2018.
Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Before joining C.R. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging Segments of Covidien International. Before that, Mr. Tornos served as International Vice President, Business Development and Strategy with Baxter International Inc. and prior to that, he spent 11 years with Johnson & Johnson in positions of increasing responsibility.
Mr. Tornos is an alumnus of the Harvard Business School having graduated from the Advanced Management Program (AMP 187) and also completed Leadership and Management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business.
Kenneth Tripp was appointed Senior Vice President, Global Operations and Logistics in April 2018.
Prior to joining the Company, Mr. Tripp served as Senior Vice President, Manufacturing at Cardinal Health. Prior to joining Cardinal Health, he served as the Vice President of Operations of the Patient Monitoring and Recovery business at Medtronic. Mr. Tripp is retired from 25 years of service in the U.S. Navy and U.S. Navy Reserve. Mr. Tripp holds a Bachelor of Arts in History and an MBA in Strategies in Organizational Leadership from Ashford University.
Sang Yi was appointed President, Asia Pacific effective June 2015. He is responsible for the sales, marketing and distribution of products in the Asia Pacific region.
Mr. Yi joined the Company (then Zimmer) in March 2013 as Senior Vice President, Asia Pacific. Before joining Zimmer, he served as Vice President and General Manager of St. Jude Medical for Asia Pacific and Australia from 2005 to 2013. Prior to that, Mr. Yi held several leadership positions over a ten-year period with Boston Scientific Corporation, ultimately serving as Vice President for North Asia. Mr. Yi holds a Bachelor of Science in Electrical Engineering from the University of South Florida.